Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA tissue cell type enrichment"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 6.8;lymphoid tissue: 13.1;stomach 1: 5.7;testis: 5.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 49.6;Late spermatids: 19.4;Paneth cells: 126.2;Proximal enterocytes: 20.4;Proximal tubular cells: 25.8"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Colon - Colon enterocytes, Skin - Adipocytes (Skin), Stomach - Parietal cells"					"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Uncertain	"Actin filaments"		NA	NA				"Cluster 3: T-cells - Adaptive immune response"	"Cluster 7: Neuronal cell lines - Stereocilium"	"Cluster 50: Enterocytes - Absorption"	"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"		
G0S2		ENSG00000123689	"G0/G1 switch 2"	P27469	1	209675412-209676390	"Metabolic proteins, Predicted intracellular proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 796.7;bone marrow: 1345.4"	"Group enriched"	"Detected in many"	5	"Langerhans cells: 6545.1;monocytes: 2147.9"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 44.5"	"Immune cell enriched"	"Detected in some"	60	"neutrophil: 549.5"	"Lineage enriched"	"Detected in many"	213	"granulocytes: 549.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 423.4"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Adipocytes (Skin)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 54: Lymphoma - Cytokine signaling"	"Cluster 75: Myeloid cells - Innate immune response"				"unprognostic (1.67e-3)"	"unprognostic (1.99e-3)"	"prognostic unfavorable (7.72e-4)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (3.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.03e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.32e-2)"	"unprognostic (8.12e-2)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (7.57e-3)"	"unprognostic (1.53e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.64e-1)"
GPAM	"GPAT1, KIAA1560, MGC26846"	ENSG00000119927	"Glycerol-3-phosphate acyltransferase, mitochondrial"	Q9HCL2	10	112149865-112215377	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 305.7;liver: 144.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 87.9;Hepatocytes: 149.2"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 20.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cancer enhanced"	"Detected in all"		"liver cancer: 45.1"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Skin - Adipocytes (Skin), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046339, HPA060090"	Approved		Approved	Mitochondria		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 59: Fibroblasts - Metabolism"	"Cluster 29: Hepatocytes - Metabolism"	Mitochondria		"HPA046339: AB_2679627, HPA060090: AB_2684202"	"unprognostic (1.82e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	"unprognostic (4.59e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.44e-2)"	"prognostic favorable (4.54e-6)"	"unprognostic (2.84e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.37e-1)"
GYG2	GN-2	ENSG00000056998	"Glycogenin 2"	O15488	X	2828822-2882820	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Glycogen biosynthesis"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adipose tissue: 156.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.4;Enteroendocrine cells: 10.1;Extravillous trophoblasts: 7.7;Granulosa cells: 10.2;Hepatocytes: 17.8"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"Bone cancer: 46.5;liver cancer: 16.8;skin cancer: 29.6;testis cancer: 59.0"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Lung - Respiratory ciliated cells, Skin - Adipocytes (Skin)"					"Low region specificity"	"Detected in all"			"HPA005495, HPA064686"	Enhanced		Approved	Nucleoplasm,Nucleoli,Cytosol		No	No				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 53: Connective tissue cells - ECM organization"	"Nucleoli, Cytosol"	Nucleoplasm	"HPA005495: AB_1079035, HPA064686: AB_2685323"	"unprognostic (4.45e-2)"	"unprognostic (4.21e-2)"	"unprognostic (6.41e-3)"	"unprognostic (8.50e-2)"	"unprognostic (2.07e-3)"	"unprognostic (5.16e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.43e-3)"	"unprognostic (6.74e-2)"	"prognostic favorable (3.01e-5)"	"unprognostic (9.76e-2)"	"unprognostic (6.10e-5)"	"unprognostic (1.78e-1)"	"unprognostic (5.05e-3)"	"unprognostic (5.41e-2)"	"unprognostic (6.60e-2)"
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 227.4;brain: 139.6;heart muscle: 307.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 47.6;Cardiomyocytes: 97.7;Cone photoreceptor cells: 24.1;Excitatory neurons: 23.0;Horizontal cells: 25.6;Inhibitory neurons: 41.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Low cancer specificity"	"Detected in all"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Skin - Adipocytes (Skin)"	"Group enriched"	"Detected in all"	4	"amygdala: 96.8;basal ganglia: 234.9;cerebral cortex: 106.9;hippocampal formation: 142.6;olfactory bulb: 144.0"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 47: Retina - Visual perception"	"Cluster 35: Bipolar cells - Visual perception"	Vesicles		"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"
LEP	"OB, OBS"	ENSG00000174697	Leptin	P41159	7	128241278-128257629	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Cancer-related genes, Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	39	"adipose tissue: 307.5;breast: 90.1"	"Group enriched"	"Detected in some"	53	"Extravillous trophoblasts: 143.0;Syncytiotrophoblasts: 380.8"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	19	"testis cancer: 2.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Adipocytes (Skin), Testis - Spermatogonia"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB010490, HPA068565"	Approved		Approved	"Vesicles,Plasma membrane"	"Secreted to blood"	NA	NA	17000000	19000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 6: BEWO - Unknown function"	"Cluster 67: Syncytiotrophoblasts - Pregnancy"	"Vesicles, Plasma membrane"		"CAB010490: AB_2296951, HPA068565: "	"unprognostic (8.19e-3)"	"unprognostic (5.33e-1)"	"unprognostic (1.60e-4)"	"unprognostic (1.19e-1)"	"unprognostic (7.99e-3)"	"unprognostic (1.83e-1)"		"unprognostic (6.56e-3)"	"unprognostic (1.98e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.84e-2)"
LPL	LIPD	ENSG00000175445	"Lipoprotein lipase"	P06858	8	19901717-19967259	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism"	"Heparin-binding, Hydrolase"	"Disease variant, FDA approved drug targets, Hyperlipidemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 937.4;heart muscle: 407.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 409.8;Cardiomyocytes: 664.2;Granulosa cells: 513.8;Schwann cells: 156.9"	"Cancer enhanced"	"Detected in all"		"glioma: 39.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 4.2"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.2"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 37.3"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Adipocytes (Skin), Testis - Endothelial cells"	"Region enhanced"	"Detected in many"		"basal ganglia: 45.3"	"Group enriched"	"Detected in all"	5	"basal ganglia: 79.2;spinal cord: 59.3"	HPA048749			Supported	Vesicles	"Secreted to blood"	NA	NA		4200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 28: Bone cancer CADO-ES1 - Glutamate signalling"	"Cluster 17: Granulosa cells - Transcription regulation"	Vesicles		"HPA048749: AB_2680511"	"unprognostic (5.52e-2)"	"unprognostic (3.16e-1)"	"unprognostic (6.41e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-4)"	"unprognostic (1.05e-1)"	"unprognostic (6.78e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.28e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.20e-3)"	"unprognostic (4.16e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (6.07e-4)"
MLXIPL	"bHLHd14, CHREBP, MIO, MONDOB, WBSCR14, WS-bHLH"	ENSG00000009950	"MLX interacting protein like"	Q9NP71	7	73593194-73624543	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"liver: 609.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 90.5;Enteroendocrine cells: 83.8;Hepatocytes: 201.1;Kupffer cells: 87.5;Proximal enterocytes: 93.9;Skeletal myocytes: 49.5"	"Cancer enriched"	"Detected in many"	6	"liver cancer: 60.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"colorectal cancer: 21.4"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Kidney - Proximal tubular cells, Lung - Alveolar cells type 2, Skin - Adipocytes (Skin)"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064640			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 19: Stomach & Colon cancer - Absorption"	"Cluster 29: Hepatocytes - Metabolism"	Nucleoplasm		"HPA064640: AB_2685309"	"unprognostic (1.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.18e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.04e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.13e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.72e-3)"
MTARC1	"FLJ22390, MARC1, MOSC1"	ENSG00000186205	"Mitochondrial amidoxime reducing component 1"	Q5VT66	1	220786913-220819659	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 192.3;breast: 86.2;liver: 84.5"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 112.3;Extravillous trophoblasts: 44.1;Prostatic glandular cells: 40.7;Syncytiotrophoblasts: 74.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 14.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	12	"basophil: 30.2;classical monocyte: 33.6;eosinophil: 12.3;neutrophil: 42.8"	"Group enriched"	"Detected in many"	31	"granulocytes: 42.8;monocytes: 33.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 70.4"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Liver - Hepatocytes, Prostate - Prostate glandular cells, Skin - Adipocytes (Skin), Thyroid - Thyroid glandular cells"									HPA028702	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 24: Prostate cancer - Lipid metabolism"	"Cluster 28: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA028702: AB_10601135"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.71e-1)"	"unprognostic (4.30e-1)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.85e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.50e-1)"
NAT8L	"FLJ37478, Hcml3, Shati"	ENSG00000185818	"N-acetyltransferase 8 like"	Q8N9F0	4	2059327-2069089	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"adipose tissue: 43.5;brain: 99.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 122.7;Excitatory neurons: 45.4;Horizontal cells: 87.8;Inhibitory neurons: 36.8;Muller glia cells: 25.8"	"Group enriched"	"Detected in many"	6	"endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Colon - Colon enteroendocrine cells, Kidney - Ascending Loop of Henle cells, Skin - Adipocytes (Skin), Testis - Sertoli cells"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040677			Approved	Mitochondria		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 16: Skin cancer - Melanocyte processes"	"Cluster 63: Astrocytes - Nervous system maintenance"	Mitochondria		"HPA040677: AB_2732486"	"unprognostic (1.32e-2)"	"unprognostic (8.62e-2)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.01e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.63e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.90e-2)"	"unprognostic (4.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.78e-3)"	"unprognostic (7.24e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.35e-2)"
PPP1R1A		ENSG00000135447	"Protein phosphatase 1 regulatory inhibitor subunit 1A"	Q13522	12	54575387-54588659	"Predicted intracellular proteins"	"Carbohydrate metabolism, Glycogen metabolism"	"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 259.7;skeletal muscle: 831.6;tongue: 271.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 439.3;Distal tubular cells: 873.8;Hepatocytes: 240.2;Proximal tubular cells: 154.9;Skeletal myocytes: 161.3"	"Cancer enhanced"	"Detected in many"		"liver cancer: 17.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	13	"Bone cancer: 62.6"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Heart muscle - Cardiomyocytes, Liver - Hepatocytes, Pancreas - Beta cells, Skin - Adipocytes (Skin)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007811, HPA041542"	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 14: Bone cancer - Transcription"	"Cluster 16: Non-specific - RNA binding"			"CAB007811: AB_598171, HPA041542: AB_2677542"	"unprognostic (6.39e-3)"	"unprognostic (2.61e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.71e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.88e-3)"	"unprognostic (7.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (8.49e-3)"	"unprognostic (7.49e-2)"
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718028	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.7;breast: 28.4;placenta: 24.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 67.0;Syncytiotrophoblasts: 168.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Cancer enhanced"	"Detected in many"		"liver cancer: 9.9"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Adipocytes (Skin)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 67: Syncytiotrophoblasts - Pregnancy"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 31.8;brain: 12.7;breast: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 39.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"Bone cancer: 1.6;Gastric cancer: 1.0"	"Adipose subcutaneous - Adipocytes (Subcutaneous), Adipose visceral - Adipocytes (Visceral), Breast - Adipocytes (Breast), Skin - Adipocytes (Skin)"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: Liver cancer - Metabolism"	"Cluster 63: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"
SPX	"C12orf39, MGC10946, NPQ, spexin"	ENSG00000134548	"Spexin hormone"	Q9BT56	12	21526296-21541249	"Predicted intracellular proteins, Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adipose tissue: 111.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 56.8;Collecting duct cells: 27.6;Distal tubular cells: 84.0;Proximal tubular cells: 239.6"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 13.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"Kidney cancer: 14.2;testis cancer: 14.6"	"Breast - Adipocytes (Breast), Colon - Enteric glia cells, Heart muscle - Cardiomyocytes, Skin - Adipocytes (Skin), Thyroid - Thyroid glandular cells"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 17.1;hippocampal formation: 17.9;olfactory bulb: 7.5;pons: 8.0"						"Secreted to blood"	NA	NA	2650000			"Cluster 82: Adipose tissue - ECM organization"	"Cluster 61: Liver - Metabolism"	"Cluster 60: Proximal tubular cells - Absorption"				"unprognostic (2.78e-2)"	"unprognostic (9.34e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.11e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.95e-1)"	"prognostic favorable (1.31e-6)"	"unprognostic (2.37e-3)"	"unprognostic (9.78e-3)"	"unprognostic (2.23e-2)"	"unprognostic (1.01e-2)"